BASILE, LIVIA
 Distribuzione geografica
Continente #
EU - Europa 189
NA - Nord America 166
AF - Africa 62
AS - Asia 14
Totale 431
Nazione #
US - Stati Uniti d'America 164
IT - Italia 86
IE - Irlanda 47
CI - Costa d'Avorio 43
BE - Belgio 18
SN - Senegal 17
DE - Germania 11
CN - Cina 10
RU - Federazione Russa 10
CH - Svizzera 4
FI - Finlandia 3
FR - Francia 3
CA - Canada 2
IN - India 2
NG - Nigeria 2
UA - Ucraina 2
BA - Bosnia-Erzegovina 1
DK - Danimarca 1
ES - Italia 1
GB - Regno Unito 1
HK - Hong Kong 1
NL - Olanda 1
UZ - Uzbekistan 1
Totale 431
Città #
Dublin 47
Chandler 45
Abidjan 43
Brussels 18
Dakar 17
Bremen 11
Lawrence 11
Andover 10
Cambridge 10
Catania 10
Ashburn 8
Barlassina 8
Des Moines 6
Jacksonville 6
Syracuse 5
Ragusa 4
Saint Petersburg 4
Boardman 3
Lappeenranta 3
Rome 3
Seattle 3
Turin 3
Wilmington 3
Abuja 2
Augusta 2
Hebei 2
San Mateo 2
Shenyang 2
Tianjin 2
Agrigento 1
Boydton 1
Central District 1
Cinisello Balsamo 1
Copenhagen 1
Den Haag 1
Ferrara di Monte Baldo 1
Granada 1
Gravina di Catania 1
Houston 1
Independence 1
Jiaxing 1
Kunming 1
Marseille 1
Mumbai 1
Nanjing 1
Ottawa 1
Paris 1
Princeton 1
Pune 1
San Francisco 1
San Vendemiano 1
Sarajevo 1
Toronto 1
Washington 1
Totale 318
Nome #
Pharmacological properties and biochemical mechanisms of MOR ligands might be due to different binding poses. MD Studies 60
Molecular modeling and biological studies show that some μ-opioid receptor agonists might elicit analgesia acting as MMP-9 inhibitors 45
Correlating in Vitro Target-Oriented Screening and Docking: Inhibition of Matrix Metalloproteinases Activities by Flavonoids 43
Quantum chemical and molecular dynamics studies of MUC-1 calix[4,8]arene scaffold based anti-cancer vaccine candidates 39
Beneficial Effects of the Very-Low-Calorie Ketogenic Diet on the Symptoms of Male Accessory Gland Inflammation 38
Molecular modeling studies on mu opioid receptor of agonists and antagonists, endogenous and exogenous, ligands 34
In-silico design and biological investigations of Diabetic Neuropathy modulators: could MOR become a focal mediator for this pathology? 34
ML10302 32
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 24
Synthesis, characterization and in silico study of novel cyclodextrin dimers 23
beta and gamma-Cyclodextrin dimers: design, characterization and in silico studies to explore the cooperative effect of the cavities 21
Parameters for irreversible inactivation of monoamine oxidase 20
New polyimidazole ligands against subclass B1 metallo-β-lactamases: Kinetic, microbiological, docking analysis 16
Interaction of natural flavonoid eriocitrin with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin: an NMR and molecular dynamics investigation 16
The in vitro inhibitory activity of polypyridine ligands towards subclass B1 metallo-β-lactamases 12
Red Wine and Sexual Function in Men: An Original Point of View 8
Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy 5
Semaglutide and obesity: beyond the nutritional and lifestyle intervention? 4
Totale 474
Categoria #
all - tutte 1.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 1 2 0
2019/202020 7 1 0 0 0 2 1 0 0 7 0 2
2020/202180 0 0 29 16 12 4 1 0 4 3 10 1
2021/202257 1 10 0 0 10 0 10 0 8 0 2 16
2022/2023186 11 5 15 19 12 27 0 40 39 3 8 7
2023/2024116 5 38 11 11 7 40 0 4 0 0 0 0
Totale 474